Trial Profile
Study of the safety and efficacy of daily tenofovir [disoproxil fumarate] to prevent HIV infection among injection drug users in Bangkok, Thailand
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 05 Feb 2022
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacodynamics
- Acronyms Bangkok Tenofovir; BTS
- 14 May 2014 Results on renal functions published in the Clinical Infectious Diseases.
- 03 Jul 2013 Results on patient compliance presented at the 7th International AIDS Society Conference on HIV Pathogenesis and Treatment.
- 12 Jun 2013 Results from the Bangkok Tenofovir Study were published online in The Lancet, according to an AVAC media release.